These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 25759103)

  • 1. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia.
    Gada H; Kirtane AJ; Kereiakes DJ; Bangalore S; Moses JW; Généreux P; Mehran R; Dangas GD; Leon MB; Stone GW
    Am J Cardiol; 2015 May; 115(9):1194-9. PubMed ID: 25759103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.
    Stergiopoulos K; Boden WE; Hartigan P; Möbius-Winkler S; Hambrecht R; Hueb W; Hardison RM; Abbott JD; Brown DL
    JAMA Intern Med; 2014 Feb; 174(2):232-40. PubMed ID: 24296791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of the Effect of Percutaneous Coronary Intervention on Death and Myocardial Infarction in Patients With Stable Coronary Artery Disease and Inducible Myocardial Ischemia.
    Radaideh Q; Osman M; Kheiri B; Al-Abdouh A; Barbarawi M; Bachuwa G; Tamis-Holland JE; Shammas NW; Boden WE
    Am J Cardiol; 2020 Oct; 133():171-174. PubMed ID: 32838929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Mohan AV; Fazel R; Huang PH; Shen YC; Howard D
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):125-30. PubMed ID: 24347661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease.
    Ujueta F; Weiss EN; Shah B; Sedlis SP
    Curr Cardiol Rep; 2017 Feb; 19(2):17. PubMed ID: 28213668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
    Phan DQ; Zadegan R; Lee MS
    J Am Geriatr Soc; 2021 Dec; 69(12):3457-3467. PubMed ID: 34363216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention for the management of stable ischemic heart disease.
    Liu S; Tsang M; Abdel-Qadir H; Yanagawa B; Bagai A
    Curr Opin Cardiol; 2019 Sep; 34(5):557-563. PubMed ID: 31246588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
    Pijls NH; Fearon WF; Tonino PA; Siebert U; Ikeno F; Bornschein B; van't Veer M; Klauss V; Manoharan G; Engstrøm T; Oldroyd KG; Ver Lee PN; MacCarthy PA; De Bruyne B;
    J Am Coll Cardiol; 2010 Jul; 56(3):177-84. PubMed ID: 20537493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population.
    Chatterjee S; Fanaroff AC; Parzynski C; Curtis J; Kolansky DM; Maddox TM; Mukherjee D; Yeh RW; Giri J
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2344-2349. PubMed ID: 34736733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Yanamala CM; Huang F
    BMC Cardiovasc Disord; 2016 Dec; 16(1):249. PubMed ID: 27912739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional flow reserve-guided PCI for stable coronary artery disease.
    De Bruyne B; Fearon WF; Pijls NH; Barbato E; Tonino P; Piroth Z; Jagic N; Mobius-Winckler S; Rioufol G; Witt N; Kala P; MacCarthy P; Engström T; Oldroyd K; Mavromatis K; Manoharan G; Verlee P; Frobert O; Curzen N; Johnson JB; Limacher A; Nüesch E; Jüni P;
    N Engl J Med; 2014 Sep; 371(13):1208-17. PubMed ID: 25176289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
    Erne P; Schoenenberger AW; Burckhardt D; Zuber M; Kiowski W; Buser PT; Dubach P; Resink TJ; Pfisterer M
    JAMA; 2007 May; 297(18):1985-91. PubMed ID: 17488963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemia.
    Choi KH; Lee JM; Park I; Kim J; Rhee TM; Hwang D; Park J; Park TK; Yang JH; Song YB; Hahn JY; Jeong DS; Cho YH; Kim WS; Sung K; Jang MJ; Sung JD; Choi JH; Choi SH; Koo BK; Lee YT; Kim EK; Chang SA; Park SJ; Choi JO; Lee SC; Park SW; Cho YS; Choi JY; Gwon HC; Oh JK
    Int J Cardiol; 2019 Feb; 277():47-53. PubMed ID: 30093138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.
    Verma S; Farkouh ME; Yanagawa B; Fitchett DH; Ahsan MR; Ruel M; Sud S; Gupta M; Singh S; Gupta N; Cheema AN; Leiter LA; Fedak PW; Teoh H; Latter DA; Fuster V; Friedrich JO
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):317-28. PubMed ID: 24622417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.
    El-Hayek GE; Gershlick AH; Hong MK; Casso Dominguez A; Banning A; Afshar AE; Herzog E; Tamis-Holland JE
    Am J Cardiol; 2015 Jun; 115(11):1481-6. PubMed ID: 25840579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease.
    Weintraub WS; Boden WE
    JAMA Intern Med; 2016 Aug; 176(8):1190-4. PubMed ID: 27380178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.